Evaluating the Market Trends of Monkeypox and How Pharma Companies are Reacting !!

The ongoing outbreak of the Monkeypox virus has attracted the eyes of many people and in the meantime worried about its incidence in the general population. Previously, Monkeypox was considered a rare disease caused by an infection due to the Monkeypox virus. The consistent rise of the Zoonosis Human Monkeypox (MPX) originated its way back from the year 1958 when two outbreaks of pox-like disease were observed in some species of monkeys, hence the name originated “Monkeypox”. The virus belongs to an Orthopoxvirus genus in the Poxvirus family. The genus also includes the outbreak of other viruses that cause similar diseases namely, cowpox virus, and variola virus (the virus causing smallpox).


What is Monkeypox?


The first-ever case of Monkeypox was seen in the Democratic Republic of Congo during a time when escalated efforts were being made to eliminate smallpox. Since that time, the spread of Monkeypox in humans has been reported in many central and western African countries. The cases of Monkeypox were observed outside of Africa also, in the countries including Singapore, the United States, and the United Kingdom, these cases were linked to the international travel or importing animals from outside the country. The actual occurrence of Monkeypox is still unknown, but evidently, African rodents and monkeys supposedly harbor the virus and the cause of Monkeypox in people.


The symptoms of Monkeypox are similar to that are seen in Smallpox, but are milder in occurrence. The symptoms of Monkeypox generally include headaches, slight fever, muscle aches, and exhaustion. The incubation time of Monkeypox is around 7-14 days, after which the mild symptoms due to the virus-like – fever, and rashes in the face starts spreading throughout the body, which can be seen effectively. The effective diagnosis of Monkeypox can be carried out successfully through the laboratory tests such as – histopathology, virus isolation test, and Polymerase Chain Reaction (PCR). 


Monkeypox Prevention 


Smallpox vaccination is seen to be a reliable option in protecting from the Monkeypox Virus but has its own limitation depending from person to person. The prevention of Monkeypox relies on limiting human contact with infected animals and reducing person-to-person transmission. A variety of precautions can be taken to avoid the infection of Monkeypox virus such as – 

  • Avoid contact with any infected animal

  • Avoid contact with contaminated bedding and other materials

  • Use a PPE kit when treating a person infected with the virus

  • Cook the food thoroughly that contains animal meat or parts

  • Make a distance from the person infected to reduce the transmission


Monkeypox Treatment

Currently, there is no approved vaccine available for the treatment of Monkeypox infections, However, the antivirals developed for use in smallpox patients may be helpful in reducing the transmission of the virus. There are some medicinal countermeasures available from the Strategic National Stockpile (SNS) as treatment options for Monkeypox, such as – Tecovirimat (SIGA Technologies), Cidofovir (Gilead), and Vaccinia Immune Globulin Intravenous (Cangene Corporation).


Is Monkeypox Deadly?


Monkeypox infection is caused by the virus of the same family that is responsible for smallpox outbreak. The severity of monkeypox is less than that of samllpox, though the symptoms of flu and illness are the same in both the diseases.


Future of Monkeypox Virus


Around 50 Monkeypox cases were reported in West Central Africa, back in the 1990s, whereas, monkeypox outbreak 2020 had a total of 5000 cases, reported of Monkeypox infection. In the current year 2022, around 1500+ cases of Monkeypox have been reported till now, in over 25+ countries.

Researchers and Scientists believe that there are still additional cases of Monkeypox which are undetected, and the virus is spreading at a greater rate. The growing prevalence in the cases of Monkeypox is serving as a medical challenge throughout the world, although potential treatments and vaccines are still one to look out for this virus.


To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services

 



Comments

Popular posts from this blog

Johnson & Johnson’s Visionary Role in Addressing Unmet Needs in Oncology

Nerve Sheath Neoplasms Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast

Pleural Effusion Treatment Devices Pleural Effusion Treatment Devices Market report from DelveInsight provides an in-depth analysis of Pleural Effusion Treatment Devices, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some Key Highlights from Pleural Effusion Treatment Devices Market Report: The underlying cause of the pleural effusion, whether breathing is impacted, and whether it is treatable efficiently all determine how serious the illness is. Heart failure, pneumonia, and viral infections are among the pleural effusion causes that are adequately treated or managed. Therapy of related mechanical issues and treatment of the underlying cause of the pleural effusion are two variables that need to be considered. Pleural Effusion Treatment Devices market is segmented based on Product Type, By Applications, and End-user. Major players which are active in the Pleural Effusion Treatment Devices market include - Pixelenergy, HEYER Medical AG, Biometrix, Redax, B. Braun Melsungen AG, OAKWORKS® Medical, Bıçakcılar Medical Equipment AS, Smiths Medical, and others. Request sample @ Pleural Effusion Treatment Devices Market Insights The market report on Pleural Effusion Treatment Devices includes an overview of the industry and a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs to identify the greatest prospects and analyze the market's underlying potential. Pleural Effusion Treatment Devices Overview The accumulation of extra fluid between the layers of the pleura outside the lungs is known as a pleural effusion, also known as "water on the lungs." The pleura, tiny membranes that line the chest cavity and the lungs, help lubricate and assist breathing. The pleura typically contains a tiny amount of fluid. Some pleural effusion patients experience no symptoms, and the illness is only identified on a chest x-ray that is taken for another cause. Due to the illness or condition that has led to the effusion, the patient may experience unrelated symptoms. Pleural Effusion Treatment Devices Market Pleural Effusion Treatment Devices are categorized By Product (Pleural Effusion Devices- Left Pleural Effusion Devices (LVAD), Percutaneous Pleural Effusion Devices (PVAD), Biventricular Pleural Effusion Devices (BIVAD), Pleural Effusion Devices), By Type (Implanted Pleural Effusion Treatment Devices, Extracorporeal Pleural Effusion Treatment Devices), By Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) The Global Pleural Effusion Treatment Devices market is expected to grow with a significant CAGR of to reach a marvelous growth in overall market size. Know more about medical devices @ Pleural Effusion Treatment Devices Market Outlook Pleural Effusion Treatment Devices Key Companies Pixelenergy HEYER Medical AG Biometrix Redax B. Braun Melsungen AG OAKWORKS® Medical Bıçakcılar Medical Equipment AS Smiths Medical Pleural Effusion Treatment Devices Market Drivers Growing number of neurological diseases Increasing Pediatric infection population Technological advancements in product development Pleural Effusion Treatment Devices Market Barriers High product pricing Stringent Regulatory Process Pleural Effusion Treatment Devices Unmet Needs Lengthy product approval process Get more insights @ Pleural Effusion Treatment Devices Major Players Scope for the Report Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan) Study Period: 2019-27 Pleural Effusion Treatment Devicess Key Companies: Pixelenergy, HEYER Medical AG, Biometrix, Redax, B. Braun Melsungen AG, OAKWORKS® Medical, Bıçakcılar Medical Equipment AS, Smiths Medical, among others. Tools Used: PEST Analysis Know more about report offerings @ Pleural Effusion Treatment Devices Market Related Reports: Laron Syndrome Pipeline "Laron Syndrome Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Laron Syndrome market. A detailed picture of the Laron Syndrome pipeline landscape is provided, which includes the disease overview and Laron Syndrome treatment guidelines. Laron Syndrome Epidemiology DelveInsight's 'Laron Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Laron Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market To know more about our Competitive Services, Click here: Pharma Competitive Intelligence https://www.delveinsight.com/consulting/competitive-intelligence-services Also, take a glance at the Blogs by DelveInsight: How Metaverse is Set to Transform the Healthcare Dynamics? Role of Mobile Technology in Hemophilia Management How 3D Bioprinting Technology is Revolutionizing the Healthcare Industry? How Cloud Computing is Transforming the Healthcare Industry Dynamics?